Compare Abbott India with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs J.B.CHEMICALS - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA J.B.CHEMICALS ABBOTT INDIA/
J.B.CHEMICALS
 
P/E (TTM) x 43.1 16.8 256.5% View Chart
P/BV x 12.3 2.3 531.9% View Chart
Dividend Yield % 0.6 0.5 110.3%  

Financials

 ABBOTT INDIA   J.B.CHEMICALS
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
J.B.CHEMICALS
Mar-18
ABBOTT INDIA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs6,110363 1,682.7%   
Low Rs3,996255 1,567.1%   
Sales per share (Unadj.) Rs1,552.2169.1 917.7%  
Earnings per share (Unadj.) Rs188.816.6 1,137.4%  
Cash flow per share (Unadj.) Rs196.423.4 838.8%  
Dividends per share (Unadj.) Rs55.002.00 2,750.0%  
Dividend yield (eoy) %1.10.6 168.2%  
Book value per share (Unadj.) Rs796.6172.5 461.8%  
Shares outstanding (eoy) m21.2583.57 25.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.31.8 178.2%   
Avg P/E ratio x26.818.6 143.7%  
P/CF ratio (eoy) x25.713.2 194.9%  
Price / Book Value ratio x6.31.8 354.1%  
Dividend payout %29.112.0 241.8%   
Avg Mkt Cap Rs m107,37625,827 415.7%   
No. of employees `0003.33.8 88.1%   
Total wages/salary Rs m3,9372,511 156.8%   
Avg. sales/employee Rs Th9,929.33,747.4 265.0%   
Avg. wages/employee Rs Th1,185.1665.7 178.0%   
Avg. net profit/employee Rs Th1,207.7367.8 328.4%   
INCOME DATA
Net Sales Rs m32,98514,135 233.4%  
Other income Rs m1,170366 319.8%   
Total revenues Rs m34,15514,501 235.5%   
Gross profit Rs m5,2452,178 240.8%  
Depreciation Rs m162570 28.4%   
Interest Rs m3835 109.5%   
Profit before tax Rs m6,2151,940 320.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203552 398.8%   
Profit after tax Rs m4,0121,387 289.2%  
Gross profit margin %15.915.4 103.2%  
Effective tax rate %35.428.5 124.5%   
Net profit margin %12.29.8 123.9%  
BALANCE SHEET DATA
Current assets Rs m22,65510,470 216.4%   
Current liabilities Rs m6,6812,749 243.0%   
Net working cap to sales %48.454.6 88.7%  
Current ratio x3.43.8 89.0%  
Inventory Days Days6555 117.4%  
Debtors Days Days2978 37.5%  
Net fixed assets Rs m8355,811 14.4%   
Share capital Rs m213167 127.2%   
"Free" reserves Rs m16,71514,248 117.3%   
Net worth Rs m16,92814,416 117.4%   
Long term debt Rs m00-   
Total assets Rs m24,16217,649 136.9%  
Interest coverage x163.756.6 289.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.40.8 170.5%   
Return on assets %16.88.1 208.0%  
Return on equity %23.79.6 246.3%  
Return on capital %36.913.7 269.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3696,164 6.0%   
Fx outflow Rs m3,8071,334 285.3%   
Net fx Rs m-3,4384,829 -71.2%   
CASH FLOW
From Operations Rs m1,5271,231 124.1%  
From Investments Rs m-2,148-208 1,032.4%  
From Financial Activity Rs m-1,024-595 172.1%  
Net Cashflow Rs m-1,646427 -385.3%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 75.0 0.3 25,000.0%  
Indian inst/Mut Fund % 7.9 3.4 233.0%  
FIIs % 0.1 3.9 2.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 37.0 46.2%  
Shareholders   18,270 30,437 60.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SANOFI INDIA  ASTRAZENECA PHARMA  STRIDES PHARMA SCIENCE  STERLING BIOTECH  JUBILANT LIFE SCIENCES  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

WPI Inflation Data, Global Stock Market Drivers, and Top Cues in Focus Today(Pre-Open)

On Monday, Indian share markets witnessed negative trading activity throughout the day and ended lower.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Sep 16, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS